|
WO1998041229A1
(en)
*
|
1997-03-19 |
1998-09-24 |
F. Hoffmann-La Roche Ag |
USE OF IL-12p40 AS IMMUNOSTIMULANT
|
|
ATE267215T1
(de)
|
1997-12-08 |
2004-06-15 |
Lexigen Pharm Corp |
Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung
|
|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
|
AU758860B2
(en)
*
|
1998-04-15 |
2003-04-03 |
Merck Patent Gmbh |
Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
|
|
WO2000015249A1
(en)
*
|
1998-09-15 |
2000-03-23 |
Genetics Institute, Inc. |
Treatment of kaposi's sarcoma with il-12
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
PL202058B1
(pl)
|
1999-08-09 |
2009-05-29 |
Merck Patent Gmbh |
Wielofunkcyjne białko fuzyjne cytokin i przeciwciała
|
|
US20030190305A1
(en)
*
|
1999-09-15 |
2003-10-09 |
Wyeth And National Institutes Of Health |
Treatment of Kaposi's sarcoma with IL-12
|
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
|
CA2387326A1
(en)
|
1999-10-11 |
2001-04-19 |
Needleless Ventures, Inc. |
Universal anti-infectious protector for needleless injectors
|
|
ES2313907T3
(es)
*
|
1999-10-29 |
2009-03-16 |
Anges Mg, Inc. |
Terapia genica para la isquemia diabetica.
|
|
EP1228214A2
(en)
|
1999-11-12 |
2002-08-07 |
MERCK PATENT GmbH |
Erythropoietin forms with improved properties
|
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
|
US7115712B1
(en)
|
1999-12-02 |
2006-10-03 |
Maxygen, Inc. |
Cytokine polypeptides
|
|
AU4314801A
(en)
|
2000-02-11 |
2001-08-20 |
Lexigen Pharm Corp |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
US20040213798A1
(en)
*
|
2000-06-08 |
2004-10-28 |
Powderject Vaccines, Inc. |
Spray-dried alum compositions
|
|
US20020120228A1
(en)
*
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
|
SK982003A3
(en)
*
|
2000-06-29 |
2004-05-04 |
Merck Patent Gmbh |
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
|
|
US20020086036A1
(en)
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
|
US7255865B2
(en)
*
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
US7148321B2
(en)
*
|
2001-03-07 |
2006-12-12 |
Emd Lexigen Research Center Corp. |
Expression technology for proteins containing a hybrid isotype antibody moiety
|
|
US6992174B2
(en)
*
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
|
US6969517B2
(en)
*
|
2001-05-03 |
2005-11-29 |
Emd Lexigen Research Center Corp. |
Recombinant tumor specific antibody and use thereof
|
|
CA2349506C
(en)
*
|
2001-06-14 |
2009-12-08 |
Duke University |
A method for selective expression of therapeutic genes by hyperthermia
|
|
ATE542137T1
(de)
*
|
2001-12-04 |
2012-02-15 |
Merck Patent Gmbh |
Immunocytokine mit modulierter selektivität
|
|
KR101086660B1
(ko)
*
|
2002-12-17 |
2011-11-24 |
메르크 파텐트 게엠베하 |
Ｇｄ2 에 결합하는 마우스 14.18 항체의 인간화 항체(ｈ14.18) 및 그것의 ｉｌ-2 와의 융합
|
|
AU2005203962C1
(en)
*
|
2004-01-05 |
2012-11-08 |
Antisoma Research Limited |
Interleukin-12 targeted to oncofoetal fibronectin
|
|
JP5175214B2
(ja)
*
|
2005-12-30 |
2013-04-03 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
改良された安定性を有するインターロイキン−１２ｐ４０変種
|
|
US7833754B2
(en)
*
|
2006-01-13 |
2010-11-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
IL-12 for expression in mammalian cell
|
|
CN101883845B
(zh)
*
|
2007-10-08 |
2015-06-10 |
英特瑞克斯顿股份有限公司 |
工程树突细胞及其在癌症治疗中的应用
|
|
CN102575227A
(zh)
|
2008-10-08 |
2012-07-11 |
英特瑞克斯顿股份有限公司 |
表达多种免疫调节剂的工程改造细胞及其应用
|
|
WO2010126766A1
(en)
*
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
WO2010147971A2
(en)
*
|
2009-06-15 |
2010-12-23 |
New York University |
Il23 modified viral vector for recombinant vaccines and tumor treatment
|
|
FI3458083T3
(fi)
|
2016-05-18 |
2023-03-01 |
|
Interleukiini-12:ta (il12) koodittavia polynukleotideja ja niiden käyttötapoja
|
|
US11421011B2
(en)
|
2017-05-18 |
2022-08-23 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|